In this issue ofUrologic Clinics of North America, guest editor Dr. Mark L. Gonzalgo brings his considerable expertise to the topic ofCurrent Management of Superficial Bladder Cancer . Non-muscle-invasive bladder cancer (NMIBC) represents approximately 75% of newly diagnosed bladder cancer cases, making its management a critical focus for urologists worldwide. In this issue, top experts address the evolving landscape of NMIBC care, from innovations in urinary biomarkers and enhanced cystoscopy techniques to advancements in intravesical therapies and personalized molecular treatment.